Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 6/2010

01-06-2010 | Original Paper

Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma

Authors: Qing Li, Hiroko Hisha, Takashi Takaki, Yasushi Adachi, Ming Li, Changye Song, Wei Feng, Satoshi Okazaki, Tomomi Mizokami, Junko Kato, Muneo Inaba, Naoki Hosaka, Masahiko Maki, Susumu Ikehara

Published in: Journal of Cancer Research and Clinical Oncology | Issue 6/2010

Login to get access

Abstract

Purpose

Bone marrow adherent cells contain conventional bone marrow stromal cells and mesenchymal stem cells and these cells constitute the hematopoietic microenvironment. Mesenchymal stem cells have the capacity to give rise to multiple mesenchymal lineage cells and even ectodermal lineage cells. In the present study, we investigated what types of tumor cells are inducible from BM adherent cells by chemical carcinogens.

Methods

Bone marrow cells from neonatal C3H/HeN mice were collected within 24 h after birth and then cultured. Four days later, bone marrow adherent cells were obtained and the cells were treated with 3-methylcholanthrene.

Results

By this treatment, some transformed clones consisting of large spindle cells were obtained. The transformed cells were highly positive for CD44 and were positive for Sca-1, CD49d and CD106, whereas the cells were negative for hematolymphoid markers. The cell clones had the ability to support hematopoiesis in vitro. These results indicate that the transformed cell lines have the characteristics of BM stromal cells/mesenchymal stem cells. Moreover, during culture of the transformed cells, spontaneous bone nodule formation was observed. When the transformed cells were inoculated into immunodeficient mice subcutaneously, the neoplasms grew in the subcutaneous tissue of the mice. Microscopically and ultrastructurally, the neoplasms showed the typical morphology of undifferentiated high-grade pleomorphic sarcoma (UHGPS). Bone-related genes have been found to be expressed in both transformed cells and UHGPSs.

Conclusion

The present study suggests that UHGPSs are derived from BM stromal cells, probably mesenchymal stem cells.
Literature
go back to reference Aaronson SA, Todaro GJ (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol 72(2):141–148CrossRefPubMed Aaronson SA, Todaro GJ (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol 72(2):141–148CrossRefPubMed
go back to reference Berwald Y, Sachs L (1965) In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Nat Cancer Inst 35(4):641–661PubMed Berwald Y, Sachs L (1965) In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Nat Cancer Inst 35(4):641–661PubMed
go back to reference Catherine AR, John SB, David WB, Charles H (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33(12):3239–3249 Catherine AR, John SB, David WB, Charles H (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33(12):3239–3249
go back to reference Erlandson RA, Antonescu CR (2004) The rise and fall of malignant fibrous histiocytoma. Ultrastruct Pathol 28(5–6):283–289CrossRefPubMed Erlandson RA, Antonescu CR (2004) The rise and fall of malignant fibrous histiocytoma. Ultrastruct Pathol 28(5–6):283–289CrossRefPubMed
go back to reference Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279(5356):1528–1530CrossRefPubMed Ferrari G, Cusella-De Angelis G, Coletta M, Paolucci E, Stornaiuolo A, Cossu G, Mavilio F (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279(5356):1528–1530CrossRefPubMed
go back to reference Fisher C (1990) The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology 16(5):441–454PubMedCrossRef Fisher C (1990) The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: a study of 200 cases. Histopathology 16(5):441–454PubMedCrossRef
go back to reference Fletcher CD, Sundaram M, Rydholm A, Coindre JM, Singer S (2002a) Soft tissue tumours: epidemiology, clinical features, histopathological typing and grading. In: Fletcher CD, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 12–18 Fletcher CD, Sundaram M, Rydholm A, Coindre JM, Singer S (2002a) Soft tissue tumours: epidemiology, clinical features, histopathological typing and grading. In: Fletcher CD, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of soft tissue and bone. IARC Press, Lyon, pp 12–18
go back to reference Fletcher CD, Berg EV, Molenaar WM (2002b) Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In: Fletcher CD, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics tumours of soft tissue and bone. ARC Press, Lyon, pp 120–122 Fletcher CD, Berg EV, Molenaar WM (2002b) Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In: Fletcher CD, Unni KK, Mertens F (eds) World Health Organization classification of tumours. Pathology and genetics tumours of soft tissue and bone. ARC Press, Lyon, pp 120–122
go back to reference Fu YS, Gabbiani G, Kaye GI, Lattes R (1975) Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytoma): general considerations and electron microscopic and tissue culture studies. Cancer 35(1):176–198CrossRefPubMed Fu YS, Gabbiani G, Kaye GI, Lattes R (1975) Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytoma): general considerations and electron microscopic and tissue culture studies. Cancer 35(1):176–198CrossRefPubMed
go back to reference Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306(5701):1568–1571CrossRefPubMed Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC (2004) Gastric cancer originating from bone marrow-derived cells. Science 306(5701):1568–1571CrossRefPubMed
go back to reference Ikehara S (1998) Bone marrow transplantation for autoimmune diseases. Acta Haematol 99(3):116–132CrossRefPubMed Ikehara S (1998) Bone marrow transplantation for autoimmune diseases. Acta Haematol 99(3):116–132CrossRefPubMed
go back to reference Ikehara S (2003) A new concept of stem cell disorders and their new therapy. J Hematother Stem Cell Res 12(6):643–653CrossRefPubMed Ikehara S (2003) A new concept of stem cell disorders and their new therapy. J Hematother Stem Cell Res 12(6):643–653CrossRefPubMed
go back to reference Iwasaki H, Isayama T, Johzaki H, Kikuchi M (1987) Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 128(3):528–537PubMed Iwasaki H, Isayama T, Johzaki H, Kikuchi M (1987) Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Am J Pathol 128(3):528–537PubMed
go back to reference Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41–49CrossRefPubMed Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893):41–49CrossRefPubMed
go back to reference Lawson CW, Fisher C, Gatter KC (1987) Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Histopathology 11(4):375–383CrossRefPubMed Lawson CW, Fisher C, Gatter KC (1987) Malignant fibrous histiocytoma. Evidence of perivascular mesenchymal cell origin immunocytochemical studies with monoclonal anti-MFH antibodies. Histopathology 11(4):375–383CrossRefPubMed
go back to reference Liu C, Chen Z, Chen Z, Zhang T, Lu Y (2006) Multiple tumor types may originate from bone marrow-derived cells. Neoplasia 8(9):716–724CrossRefPubMed Liu C, Chen Z, Chen Z, Zhang T, Lu Y (2006) Multiple tumor types may originate from bone marrow-derived cells. Neoplasia 8(9):716–724CrossRefPubMed
go back to reference Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C (2007) Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 117(11):3248–3257CrossRefPubMed Matushansky I, Hernando E, Socci ND, Mills JE, Matos TA, Edgar MA, Singer S, Maki RG, Cordon-Cardo C (2007) Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 117(11):3248–3257CrossRefPubMed
go back to reference Meirelles Lda S, Nardi NB (2003) Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123(4):702–711CrossRefPubMed Meirelles Lda S, Nardi NB (2003) Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123(4):702–711CrossRefPubMed
go back to reference Montgomery E, Fisher C (2001) Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 38(6):499–509CrossRefPubMed Montgomery E, Fisher C (2001) Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study. Histopathology 38(6):499–509CrossRefPubMed
go back to reference Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147CrossRefPubMed Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143–147CrossRefPubMed
go back to reference Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309):71–74CrossRefPubMed Prockop DJ (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276(5309):71–74CrossRefPubMed
go back to reference Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33(12):3239–3249PubMed Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C (1973) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33(12):3239–3249PubMed
go back to reference Riggi N, Cironi L, Provero P, Suvà ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I (2005) Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65(24):11459–11468CrossRefPubMed Riggi N, Cironi L, Provero P, Suvà ML, Kaloulis K, Garcia-Echeverria C, Hoffmann F, Trumpp A, Stamenkovic I (2005) Development of Ewing’s sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res 65(24):11459–11468CrossRefPubMed
go back to reference Riggi N, Cironi L, Provero P, Suvà ML, Stehle JC, Baumer K, Guillou L, Stamenkovic I (2006) Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66(14):7016–7023CrossRefPubMed Riggi N, Cironi L, Provero P, Suvà ML, Stehle JC, Baumer K, Guillou L, Stamenkovic I (2006) Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res 66(14):7016–7023CrossRefPubMed
go back to reference Rosenberg AE (2003) Malignant fibrous histiocytoma: past, present, and future. Skelet Radiol 32(11):613–618CrossRef Rosenberg AE (2003) Malignant fibrous histiocytoma: past, present, and future. Skelet Radiol 32(11):613–618CrossRef
go back to reference Rosenberg AE, O’Connell JX, Dickersin GR, Bhan AK (1993) Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol 24(3):284–293CrossRefPubMed Rosenberg AE, O’Connell JX, Dickersin GR, Bhan AK (1993) Expression of epithelial markers in malignant fibrous histiocytoma of the musculoskeletal system: an immunohistochemical and electron microscopic study. Hum Pathol 24(3):284–293CrossRefPubMed
go back to reference Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrødder H, Jensen T, Kassem M (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23(29):5095–5098CrossRefPubMed Serakinci N, Guldberg P, Burns JS, Abdallah B, Schrødder H, Jensen T, Kassem M (2004) Adult human mesenchymal stem cell as a target for neoplastic transformation. Oncogene 23(29):5095–5098CrossRefPubMed
go back to reference Tos AP (2006) Classification of pleomorphic sarcomas: where are we now? Histopathology 48(1):51–62CrossRef Tos AP (2006) Classification of pleomorphic sarcomas: where are we now? Histopathology 48(1):51–62CrossRef
go back to reference Turksen K, Aubin JE (1991) Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 114(2):373–384CrossRefPubMed Turksen K, Aubin JE (1991) Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 114(2):373–384CrossRefPubMed
go back to reference Wang X, Hisha H, Taketani S, Adachi Y, Li Q, Cui W, Cui Y, Wang J, Song C, Mizokami T, Okazaki S, Li Q, Fan T, Fan H, Lian Z, Gershwin ME, Ikehara S (2006) Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 24(3):482–493CrossRefPubMed Wang X, Hisha H, Taketani S, Adachi Y, Li Q, Cui W, Cui Y, Wang J, Song C, Mizokami T, Okazaki S, Li Q, Fan T, Fan H, Lian Z, Gershwin ME, Ikehara S (2006) Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 24(3):482–493CrossRefPubMed
go back to reference Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL, Warnke RA (1986) Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 10(5):323–335CrossRefPubMed Wood GS, Beckstead JH, Turner RR, Hendrickson MR, Kempson RL, Warnke RA (1986) Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol 10(5):323–335CrossRefPubMed
go back to reference Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370CrossRefPubMed Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61(4):364–370CrossRefPubMed
go back to reference Yamate J, Ogata K, Yuasa T, Kuwamura M, Takenaka S, Kumagai D, Itoh K, LaMarre J (2007) Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells. Eur J Cancer 43(18):2747–2756CrossRefPubMed Yamate J, Ogata K, Yuasa T, Kuwamura M, Takenaka S, Kumagai D, Itoh K, LaMarre J (2007) Adipogenic, osteogenic and myofibrogenic differentiations of a rat malignant fibrous histiocytoma (MFH)-derived cell line, and a relationship of MFH cells with embryonal mesenchymal, perivascular and bone marrow stem cells. Eur J Cancer 43(18):2747–2756CrossRefPubMed
Metadata
Title
Transformation potential of bone marrow stromal cells into undifferentiated high-grade pleomorphic sarcoma
Authors
Qing Li
Hiroko Hisha
Takashi Takaki
Yasushi Adachi
Ming Li
Changye Song
Wei Feng
Satoshi Okazaki
Tomomi Mizokami
Junko Kato
Muneo Inaba
Naoki Hosaka
Masahiko Maki
Susumu Ikehara
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 6/2010
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0723-0

Other articles of this Issue 6/2010

Journal of Cancer Research and Clinical Oncology 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine